India Stem Cell Market Competition Forecast & Opportunities, 2026 by Product Type (Adult; Induced Pluripotent; Human Embryonic), Application (Regenerative Medicine Vs. Drug Discovery & Development) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User, By Technology, By Region, Competition Forecast & Opportunities, FY 2026” report has been added to ResearchAndMarkets.com’s offering.
The Indian Stem Cell Market was valued at USD 0.47 Billion in 2019 and is projected to grow at around 13% CAGR during FY 2021 – FY 2026.
Continuous advancements in tissue engineering is one of the prime factors boosting the Indian Stem Cell Market. Development of regenerative medicines coupled with growing cases of chronic and genetic diseases across the country are some of the other factors anticipated to drive the growth of stem cell market during the forecast years.
Moreover, availability of funds from the government and certain organizations is estimated to bode well for the growth of the Indian Stem Cell Market over the next five years.
The Indian Stem Cell Market is segmented based on product type, application, technology, end-user and region. Based on product type, the market can be categorized into adult, induced pluripotent, human embryonic and others. Out of these, the adult stem cells segment dominated the market until FY 2020 and is further expected to maintain its leading position in the market during the forecast period as well on account of reduced contamination risk associated with sub-culturing.
Moreover, its compatibility with the human body is expected to drive the segment growth over the coming years. Additionally, less requirement for production labor is boosting the growth of adult stem cells segment.
Major players operating in the Indian Stem Cell Market include Thermofisher Scientific India Pvt. Ltd., Pluristem Technologies Ltd., Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd., Merck Lifescience Pvt. Ltd., Cordlife India Pvt. Ltd., LifeCell International Pvt. Ltd., StemCyte India Therapeutics Private Limited, Stempeutics Research Private Limited, ReeLabs Private Limited, among others.
The companies are focussing on extensive research and developments activities in order to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.
Key Target Audience:
- Stem cell companies, medical research institutes and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to stem cell
Years considered for this report:
- Historical Years: FY 2016 – FY 2019
- Base Year: FY 2020
- Estimated Year: FY 2021
- Forecast Period: FY 2022 – FY 2026
Key Topics Covered:
1. Product of Interest Introduction: Stem Cell
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. India Stem Cell Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others)
5.2.2. By Application (Regenerative Medicine Vs. Drug Discovery & Development)
5.2.3. By Technology (Cell Acquisition; Cell Production; Cryopreservation; Expansion & Subculture)
5.2.4. By End User (Pharmaceutical/Biotechnology Companies, CRO)
5.2.5. By Region (North, South, East, West)
5.2.6. By Company
5.3. Product Market Map
6. India Stem Cell Acquisition Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
6.2.2. By Type (Bone Marrow Harvest; Umbilical Blood Cord; and Apheresis)
7. India Stem Cell Production Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
7.2.2. By Type (Therapeutic cloning; In vitro fertilization; Cell culture; and Isolation)
8. India Stem Cell Cryopreservation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
9. India Stem Cell Expansion & Sub-culture Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
10. Market Dynamics
10.1. Drivers/Opportunities
10.2. Challenges/Restraints
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. India Economic Profile
14. Competitive Landscape
14.1. Company Profiles
14.1.1. Thermofisher Scientific India Pvt. Ltd.
14.1.2. Pluristem Technologies Ltd.
14.1.3. Becton Dickinson Private Limited
14.1.4. Stem Cell Technologies India Pvt. Ltd.
14.1.5. Merck Lifescience Pvt. Ltd.
14.1.6. Cordlife India Pvt. Ltd.
14.1.7. LifeCell International Pvt. Ltd.
14.1.8. StemCyte India Therapeutics Private Limited
14.1.9. Stempeutics Research Private Limited
14.1.10. ReeLabs Private Limited
15. Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/wlmds7
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
